Anh Thu Tran1, Malathi Ramalinga, Habib Kedir, Robert Clarke, Deepak Kumar. 1. Cancer Research Laboratory, Department of Biology and Chemistry, University of the District of Columbia, Building 44, Room 312, 4200 Connecticut Avenue, NW, Washington, DC, 20008, USA.
Abstract
INTRODUCTION: Tocomin® represents commercially available mixture of naturally occurring tocotrienols (T3s) and tocopherols extracted from palm oil/palm fruits that possess powerful antioxidant, anticancer, neuro/cardioprotective and cholesterol-lowering properties. Cellular autophagy represents a defense mechanism against oxidative stress and several anticancer compounds. Recently, we reported that T3s induce apoptosis and endoplasmic reticulum stress in breast cancer cells. METHODOLOGY: We studied the effects of Tocomin® on MCF-7 and MDA-MB 231 breast cancer cells and non-tumor MCF-10A cells. RESULTS: Tocomin® inhibited cell proliferation and induced apoptosis in both MCF-7 and MDA-MB 231 breast cancer cell lines without affecting the viability of MCF-10A cells. We also showed that Tocomin® negatively modulates phosphoinositide 3-kinase and mTOR pathways and induces cytoprotective autophagic response in triple negative MDA-MB 231 cells. Lastly, we demonstrate that autophagy inhibitor 3-methyladenine (3-MA) potentiated the apoptosis induced by Tocomin® in MDA-MB 231 cells. CONCLUSION: Together, our data indicate anticancer effects of Tocomin® in breast cancer cells, which is potentiated by the autophagy inhibitor 3-MA.
INTRODUCTION:Tocomin® represents commercially available mixture of naturally occurring tocotrienols (T3s) and tocopherols extracted from palm oil/palm fruits that possess powerful antioxidant, anticancer, neuro/cardioprotective and cholesterol-lowering properties. Cellular autophagy represents a defense mechanism against oxidative stress and several anticancer compounds. Recently, we reported that T3s induce apoptosis and endoplasmic reticulum stress in breast cancer cells. METHODOLOGY: We studied the effects of Tocomin® on MCF-7 and MDA-MB 231breast cancer cells and non-tumorMCF-10A cells. RESULTS:Tocomin® inhibited cell proliferation and induced apoptosis in both MCF-7 and MDA-MB 231breast cancer cell lines without affecting the viability of MCF-10A cells. We also showed that Tocomin® negatively modulates phosphoinositide 3-kinase and mTOR pathways and induces cytoprotective autophagic response in triple negative MDA-MB 231 cells. Lastly, we demonstrate that autophagy inhibitor 3-methyladenine (3-MA) potentiated the apoptosis induced by Tocomin® in MDA-MB 231 cells. CONCLUSION: Together, our data indicate anticancer effects of Tocomin® in breast cancer cells, which is potentiated by the autophagy inhibitor 3-MA.
Authors: Sonyo Shin-Kang; Victoria P Ramsauer; Janet Lightner; Kanishka Chakraborty; William Stone; Sharon Campbell; Shrikanth A G Reddy; Koyamangalath Krishnan Journal: Free Radic Biol Med Date: 2011-06-21 Impact factor: 7.376
Authors: Jennifer S Carew; Ernest C Medina; Juan A Esquivel; Devalingam Mahalingam; Ronan Swords; Kevin Kelly; Hui Zhang; Peng Huang; Alain C Mita; Monica M Mita; Francis J Giles; Steffan T Nawrocki Journal: J Cell Mol Med Date: 2010-10 Impact factor: 5.310
Authors: Khaled S Allemailem; Ahmad Almatroudi; Faris Alrumaihi; Saleh A Almatroodi; Mohammad O Alkurbi; Ghaiyda Talal Basfar; Arshad Husain Rahmani; Amjad Ali Khan Journal: Int J Nanomedicine Date: 2021-07-26
Authors: Amrita K Cheema; Irene Maier; Tyrone Dowdy; Yiwen Wang; Rajbir Singh; Paul M Ruegger; James Borneman; Albert J Fornace; Robert H Schiestl Journal: PLoS One Date: 2016-04-13 Impact factor: 3.240